84218-41-7 Usage
Molecular structure
TDIQ has a complex molecular structure, which includes a tetrahydroisoquinoline core, two methoxy groups, an indole ring, and a toluene moiety.
Classification
It belongs to the class of isoquinoline alkaloids, which are naturally occurring organic compounds.
Acetylcholinesterase inhibition
TDIQ is a potent inhibitor of acetylcholinesterase, an enzyme responsible for breaking down the neurotransmitter acetylcholine.
Therapeutic potential
Due to its acetylcholinesterase inhibitory activity, TDIQ has been investigated for its potential therapeutic applications, particularly in the treatment of neurodegenerative disorders.
Alzheimer's disease treatment
TDIQ has shown promise in the treatment of Alzheimer's disease, a progressive neurodegenerative disorder characterized by memory loss and cognitive decline.
Intricate molecular structure
The complex structure of TDIQ contributes to its pharmacological effects and makes it an interesting subject for further research.
Drug development potential
TDIQ's molecular structure and pharmacological effects make it a promising candidate for the development of new drugs targeting neurodegenerative disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 84218-41-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,2,1 and 8 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 84218-41:
(7*8)+(6*4)+(5*2)+(4*1)+(3*8)+(2*4)+(1*1)=127
127 % 10 = 7
So 84218-41-7 is a valid CAS Registry Number.
InChI:InChI=1/C28H31N3O2/c1-19-8-4-6-10-24(19)30-18-31-13-12-20-15-27(32-2)28(33-3)16-23(20)26(31)14-21-17-29-25-11-7-5-9-22(21)25/h4-11,15-17,26,29-30H,12-14,18H2,1-3H3
84218-41-7Relevant articles and documents
Antiinflammatory and antiproteolytic activities of newer indolyl isoquinolines
Tandon,Tandon,Barthwal,Bhalla,Bhargava
, p. 1233 - 1235 (2007/10/02)
Several indolyl isoquinoline derivatives were synthesized and evaluated for their antiinflammatory and antiproteolytic activities. These derivatives possessed 9.2-32.4% inhibition at a dose of 100 mg/kg i.p. against carrageenin-induced oedema. Four of the